Details for Patent: 9,399,025

Summary for Patent: 9,399,025

Patent landscape, scope, and claims:

Title:	Modified release dosage forms of skeletal muscle relaxants
Abstract:	A unit dosage form, such as a capsule or the like, for delivering a skeletal muscle relaxant, such as cyclobenzaprine hydrochloride, into the body in an extended or sustained release fashion comprising one or more populations of drug-containing particles (beads, pellets, granules, etc.) is disclosed. At least one bead population exhibits a pre-designed sustained release profile. Such a drug delivery system is designed for once-daily oral administration to maintain an adequate plasma concentration--time profile, thereby providing relief of muscle spasm associated with painful musculoskeletal conditions over a 24 hour period.
Inventor(s):	Venkatesh; Gopi M. (Vandalia, OH), Clevenger; James M. (Vandalia, OH)
Assignee:	ADARE PHARMACEUTICALS, INC. (Lawrenceville, NJ)
Application Number:	14/563,580
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,399,025
Patent Claim Types: see list of patent claims	Formulation; Compound; Dosage form; Use;

Drugs Protected by US Patent 9,399,025

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 9,399,025

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
World Intellectual Property Organization (WIPO)	2005048996